Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000721748-14-000804
Filing Date
2014-08-13
Accepted
2014-08-13 14:33:00
Documents
13
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 mspc10q063014.htm 10-Q 175518
2 CONVERTIBLE PROMISSORY NOTE EXCHANGE AGREEMENT mspc10q063014ex10_16.htm EX-10.16 76599
3 CONVERTIBLE PROMISSORY NOTE mspc10q063014ex10_17.htm EX-10.17 13073
4 AGREEMENT OF AMENDMENT AND RESCISSION mspc10q063014ex10_18.htm EX-10.18 14375
5 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER OF METROSPACES, INC. PURSUANT TO SE mspc10q063014ex31_1.htm EX-31.1 6726
6 mspc10q063014ex32_1.htm EX-32.1 3294
7 GRAPHIC image_001.gif GRAPHIC 49
  Complete submission text file 0000721748-14-000804.txt   1559241

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE mspc-20140630.xml EX-101.INS 97891
9 XBRL SCHEMA FILE mspc-20140630.xsd EX-101.SCH 18248
10 XBRL CALCULATION FILE mspc-20140630_cal.xml EX-101.CAL 23733
11 XBRL DEFINITION FILE mspc-20140630_def.xml EX-101.DEF 26542
12 XBRL LABEL FILE mspc-20140630_lab.xml EX-101.LAB 111332
13 XBRL PRESENTATION FILE mspc-20140630_pre.xml EX-101.PRE 93631
Mailing Address 888 BRICKELL KEY DR. UNIT 1102 MIAMI FL 33131
Business Address 888 BRICKELL KEY DR. UNIT 1102 MIAMI FL 33131 3056000407
METROSPACES, INC. (Filer) CIK: 0001488501 (see all company filings)

EIN.: 000000000 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36220 | Film No.: 141037038
SIC: 2835 In Vitro & In Vivo Diagnostic Substances